Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.62, No.3, p.353-364, 2015 |
||
Title: RAGE and its ligands in cancer – culprits, biomarkers, or therapeutic targets? | ||
Author: P. TESAROVA, M. CABINAKOVA, V. MIKULOVA, T. ZIMA, M. KALOUSOVA | ||
Abstract: Receptor for advanced glycation end products (RAGE) plays a central role in the regulation of tissue homeostasis, regeneration and resolution of inflammation, but under pathological conditions RAGE-mediated pathways may induce diminished apoptosis, but enhanced autophagy and cell necrosis. These mechanisms may contribute to malignant transformation, cancer progression and metastases. Soluble RAGE may bind natural RAGE ligands and counteract some of the RAGE-mediated effects. Activation of RAGE was demonstrated in different types of cancer (including colon, pancreatic and breast cancer). Expression of RAGE and serum levels of soluble RAGE may serve as cancer biomarkers and strategies aimed at interfering with RAGE signaling might be promising anticancer drugs. |
||
Keywords: RAGE, cancer, HMGB1, S100 proteins | ||
Published online: 11-May-2015 | ||
Year: 2015, Volume: 62, Issue: 3 | Page From: 353, Page To: 364 | |
doi:10.4149/neo_2015_061 |
||
|
download file |
|